Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study

Colorectal cancers are one of the most prevalent tumour types worldwide and, despite the emergence of targeted and biologic therapies, have among the highest mortality rates. The Personalized OncoGenomics (POG) program at BC Cancer performs whole genome and transcriptome analysis (WGTA) to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Titmuss, E., Milne, K., Jones, M. R., Ng, T., Topham, J. T., Brown, S. D., Schaeffer, D. F., Kalloger, S., Wilson, D., Corbett, R. D., Williamson, L. M., Mungall, K., Mungall, A. J., Holt, R. A., Nelson, B. H., Jones, S. J. M., Laskin, J., Lim, H. J., Marra, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051648/
https://www.ncbi.nlm.nih.gov/pubmed/36982943
http://dx.doi.org/10.3390/ijms24065869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051648/
https://www.ncbi.nlm.nih.gov/pubmed/36982943
http://dx.doi.org/10.3390/ijms24065869

Ejemplares similares